As demand for weight-loss drugs rises, states grapple with Medicaid coverage In January, the National Association of Medicaid Directors told the federal Centers for Medicare & Medicaid Services that state Medicaid departments had significant concerns over the fiscal impacts of the Biden proposal to require coverage of GLP-1s, and strongly recommend that CMS maintain the current state option to cover or not cover anti-obesity medications. But others say covering the drugs will yield long-term savings
Theyre more likely to contain herbal supplements and vitamins such as green tea extract, berberine, chromium, L-glutamine, garcinia cambogia, bitter orange extract, Vitamin B complex, guarana, and L-carnitine
If binge eating is present, best practice is specialist evaluation
Exenatide (Byetta): risk of severe pancreatitis and renal failure
Yes, though the transition requires careful dose management
AlexisSanta Maria, CA With many options out there it is hard to know where to go for your research peptides
